Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes (CROSBI ID 325807)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Rudman, Najda ; Kaur, Simranjeet ; Simunović, Vesna ; Kifer, Domagoj ; Šoić, Dinko ; Keser, Toma ; Štambuk, Tamara ; Klarić, Lucija ; Pociot, Flemming ; Morahan, Grant et al. Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes // Diabetologia (Berlin), 66 (2023), 6; 1071-1083. doi: 10.1007/s00125-023-05881-z

Podaci o odgovornosti

Rudman, Najda ; Kaur, Simranjeet ; Simunović, Vesna ; Kifer, Domagoj ; Šoić, Dinko ; Keser, Toma ; Štambuk, Tamara ; Klarić, Lucija ; Pociot, Flemming ; Morahan, Grant ; Gornik, Olga

engleski

Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes

Aims/hypothesis: We previously demonstrated that N-glycosylation of plasma proteins and IgGs is different in children with recent-onset type 1 diabetes compared with their healthy siblings. To search for genetic variants contributing to these changes, we undertook a genetic association study of the plasma protein and IgG N-glycome in type 1 diabetes. Methods: A total of 1105 recent-onset type 1 diabetes patients from the Danish Registry of Childhood and Adolescent Diabetes were genotyped at 183, 546 genetic markers, testing these for genetic association with variable levels of 24 IgG and 39 plasma protein N-glycan traits. In the follow-up study, significant associations were validated in 455 samples. Results: This study confirmed previously known plasma protein and/or IgG N-glycosylation loci (candidate genes MGAT3, MGAT5 and ST6GAL1, encoding beta-1, 4-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase, alpha-1, 6- mannosylglycoprotein 6-beta-N- acetylglucosaminyltransferase and ST6 beta- galactoside alpha-2, 6-sialyltransferase 1 gene, respectively) and identified novel associations that were not previously reported for the general European population. First, novel genetic associations of IgG-bound glycans were found with SNPs on chromosome 22 residing in two genomic intervals close to candidate gene MGAT3 ; these include core fucosylated digalactosylated disialylated IgG N-glycan with bisecting N- acetylglucosamine (GlcNAc) (pdiscovery=7.65 × 10- 12, preplication=8.33 × 10-6 for the top associated SNP rs5757680) and core fucosylated digalactosylated glycan with bisecting GlcNAc (pdiscovery=2.88 × 10-10, preplication=3.03 × 10-3 for the top associated SNP rs137702). The most significant genetic associations of IgG-bound glycans were those with MGAT3. Second, two SNPs in high linkage disequilibrium (missense rs1047286 and synonymous rs2230203) located on chromosome 19 within the protein coding region of the complement C3 gene (C3) showed association with the oligomannose plasma protein N-glycan (pdiscovery=2.43 × 10-11, preplication=8.66 × 10-4 for the top associated SNP rs1047286). Conclusions/interpretation: This study identified novel genetic associations driving the distinct N- glycosylation of plasma proteins and IgGs identified previously at type 1 diabetes onset. Our results highlight the importance of further exploring the potential role of N-glycosylation and its influence on complement activation and type 1 diabetes susceptibility.

C3 ; GWAS ; IgG N-glycosylation ; MGAT3 ; ST6GAL1 ; plasma protein N-glycosylation ; type 1 diabetes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

66 (6)

2023.

1071-1083

objavljeno

0012-186X

1432-0428

10.1007/s00125-023-05881-z

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost